Could carbamazepine-acetazolamide interaction lead to a severe hepatocellular liver injury? an interaction that needs to be uncovered

Patsalos PN, Zugman M, Lake C, James A, Ratnaraj N, Sander JW (2017) Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: a comparison of free non–protein-bound concentrations. Epilepsia 58(7):1234–1243

Article  CAS  PubMed  Google Scholar 

Horn JR, Hansten PD, Chan LN (2007) Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 41(4):674–680

Article  PubMed  Google Scholar 

Carbamazepine [Internet] (2017) LiverTox: clinical and research information on drug-induced liver injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases [cited 2022 Nov 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548097/

Ganesh S, Shukla L, Kandasamy A, Benegal V (2017) A case of carbamazepine-induced severe cholestatic hepatitis: case report and review of literature. Indian J Psychol Med 39(5):688–690

Article  PubMed  PubMed Central  Google Scholar 

Kaplowitz N, DeLeve LD (2013) editors. Drug-induced liver disease. Third edition. London, UK ; Waltham, MA: Elsevier/AP 746 p

Patsalos PN, Spencer EP, Berry DJ (2018) Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update. Ther Drug Monit 40(5):526–548

Article  CAS  PubMed  Google Scholar 

Forsythe WI, Owens JR, Toothill C (1981) Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children. Dev Med Child Neurol 23(6):761–769

CAS  PubMed  Google Scholar 

Tolou-Ghamari Z, Zare MH, Habibabadi JM, Najafi MR (2013) A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012. J Res Med Sci Off J Isfahan Univ Med Sci [Internet]. [cited 2022 Nov 1]; Available from: https://www.scienceopen.com/document?vid=04c7390d-52dd-42fc-9ef6-7b4426fc1815

Patsalos PN (2013) Acetazolamide. In: Patsalos PN, editor. Antiepileptic drug interactions: a clinical guide [Internet]. London: Springer [cited 2022 Nov 1]. p. 5–9. Available from: https://doi.org/10.1007/978-1-4471-2434-4_1

Barre J, Didey F, Delion F, Tillement JP (1988) Problems in therapeutic drug monitoring: free drug level monitoring. Ther Drug Monit 10(2):133–143

Article  CAS  PubMed  Google Scholar 

Charlier B, Coglianese A, De Rosa F, de Grazia U, Operto FF, Coppola G et al (2021) The effect of plasma protein binding on the therapeutic monitoring of antiseizure medications. Pharmaceutics 13(8):1208

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif